Metabolic Syndrome in Korean Cancer Survivors and Family Members: A Study in a Health Promotion Center

REFERENCES

• Jung KW, Won YJ, Kong HJ, Oh CM, Cho H, et al.: Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2012. Cancer Res Treat 47, 127–141, 2015.
   Web of Science ®Google Scholar
• Prasad PK, Signorello LB, Friedman DL, Boice JD, Jr., and Pukkala E: Long-term non-cancer mortality in pediatric and young adult cancer survivors in Finland. Pediatr Blood Cancer 58, 421–427, 2012.
   PubMed Web of Science ®Google Scholar
• Castellino SM, Geiger AM, Mertens AC, Leisenring WM, Tooze JA, et al.: Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study. Blood 117, 1806–1816, 2011.
   PubMed Web of Science ®Google Scholar
• Armstrong GT, Liu Q, Yasui Y, Neglia JP, Leisenring W, et al.: Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. J Clin Oncol 27, 2328–2338, 2009.
   PubMed Web of Science ®Google Scholar
• Rosen GP, Nguyen HT, and Shaibi GQ: Metabolic syndrome in pediatric cancer survivors: a mechanistic review. Pediatr Blood Cancer 60, 1922–1928, 2013.
   PubMed Web of Science ®Google Scholar
• Braga-Basaria M, Dobs AS, Muller DC, Carducci MA, John M, et al.: Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. J Clin Oncol 24, 3979–3983, 2006.
   PubMed Web of Science ®Google Scholar
• Traish AM, Saad F, Feeley RJ, and Guay A: The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 30, 477–494, 2009.
   PubMed Web of Science ®Google Scholar
• Bizzarri C, Bottaro G, Pinto RM, and Cappa M: Metabolic syndrome and diabetes mellitus in childhood cancer survivors. Pediatr Endocrinol Rev 11, 365–373, 2014.
   PubMed Web of Science ®Google Scholar
• Redig AJ and Munshi HG: Care of the cancer survivor: metabolic syndrome after hormone-modifying therapy. Am J Med 123, 87, e81–86, 2010.
   Google Scholar
• von Gruenigen VE, Waggoner SE, Frasure HE, Kavanagh MB, Janata JW, et al.: Lifestyle challenges in endometrial cancer survivorship. Obstet Gynecol 117, 93–100, 2011.
   PubMed Web of Science ®Google Scholar
• Kim KH, Cho YY, Shin DW, Lee JH, Ko YJ, et al.: Comparison of physical and mental health status between cancer survivors and the general population: a Korean population-based survey (KNHANES II-IV). Support Care Cancer 21, 3471–3481, 2013.
   PubMed Web of Science ®Google Scholar
• Shin DW, Cho B, Kim SY, Jung JH, and Park JH: Management of cancer survivors in clinical and public health perspectives: current status and future challenges in Korea. J Korean Med Sci 28, 651–657, 2013.
   PubMed Web of Science ®Google Scholar
• Paik HY: Dietary Reference Intakes for Koreans (KDRIs). Asia Pac J Clin Nutr 17(Suppl 2), 416–419, 2008.
   PubMed Web of Science ®Google Scholar
• Stevens LA, Coresh J, Greene T, and Levey AS: Assessing kidney function—measured and estimated glomerular filtration rate. N Engl J Med 354, 2473–2483, 2006.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al.: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419, 1985.
   PubMed Web of Science ®Google Scholar
• Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, et al.: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 13, 322–327, 2005.
   PubMedGoogle Scholar
• Lee SY, Park HS, Kim DJ, Han JH, Kim SM, et al.: Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 75, 72–80, 2007.
   PubMed Web of Science ®Google Scholar
• Lee JY, Park NH, Song YS, Park SM, Lee HW, et al.: Prevalence of the metabolic syndrome and associated factors in korean cancer survivors. Asian Pac J Cancer Prev 14, 1773–1780, 2013.
   PubMed Web of Science ®Google Scholar
• Jung HS, Myung SK, Kim BS, and Seo HG: Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract 95, 275–282, 2012.
   PubMed Web of Science ®Google Scholar
• Pourcher G, De Filippo G, Ferretti S, Piquard C, Dagher I, et al.: Short-term results of single-port sleeve gastrectomy in adolescents with severe obesity. Surg Obes Relat Dis 11, 65–69, 2015.
   Web of Science ®Google Scholar
• Buttros Dde A, Nahas EA, Vespoli Hde L, Uemura G, de Almeida Bda R, et al.: Risk of metabolic syndrome in postmenopausal breast cancer survivors. Menopause 20, 448–454, 2013.
   PubMed Web of Science ®Google Scholar
• McDonald CC, Alexander FE, Whyte BW, Forrest AP, and Stewart HJ: Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial. The Scottish Cancer Trials Breast Group. BMJ 311, 977–980, 1995.
   Google Scholar
• Saarto T, Blomqvist C, Ehnholm C, Taskinen MR, and Elomaa I: Effects of chemotherapy-induced castration on serum lipids and apoproteins in premenopausal women with node-positive breast cancer. J Clin Endocrinol Metab 81, 4453–4457, 1996.
   PubMed Web of Science ®Google Scholar
• Cuppone F, Bria E, Verma S, Pritchard KI, Gandhi S, et al.: Do adjuvant aromatase inhibitors increase the cardiovascular risk in postmenopausal women with early breast cancer? Meta-analysis of randomized trials. Cancer 112, 260–267, 2008.
   PubMed Web of Science ®Google Scholar
• Makari-Judson G, Braun B, Jerry DJ, and Mertens WC: Weight gain following breast cancer diagnosis: Implication and proposed mechanisms. World J Clin Oncol 5, 272–282, 2014.
   PubMedGoogle Scholar
• Demark-Wahnefried W, Peterson BL, Winer EP, Marks L, Aziz N, et al.: Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 19, 2381–2389, 2001.
   PubMed Web of Science ®Google Scholar
• Nuver J, Smit AJ, Postma A, Sleijfer DT, and Gietema JA: The metabolic syndrome in long-term cancer survivors, an important target for secondary preventive measures. Cancer Treat Rev 28, 195–214, 2002.
   PubMed Web of Science ®Google Scholar
• van Waas M, Neggers SJ, Raat H, van Rij CM, Pieters R, et al.: Abdominal radiotherapy: a major determinant of metabolic syndrome in nephroblastoma and neuroblastoma survivors. PLoS One 7, e52237, 2012.
   PubMed Web of Science ®Google Scholar
• van Waas M, Neggers SJ, Uitterlinden AG, Blijdorp K, van der Geest IM, et al.: Treatment factors rather than genetic variation determine metabolic syndrome in childhood cancer survivors. Eur J Cancer 49, 668–675, 2013.
   PubMed Web of Science ®Google Scholar
• Smith WA, Li C, Nottage KA, Mulrooney DA, Armstrong GT, et al.: Lifestyle and metabolic syndrome in adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort Study. Cancer 120, 2742–2750, 2014.
   PubMed Web of Science ®Google Scholar
• Spadafranca A, Cappelletti C, Leone A, Vignati L, Battezzati A, et al.: Relationship between thyroid hormones, resting energy expenditure and cardiometabolic risk factors in euthyroid subjects. Clin Nutr, 2014.
   Web of Science ®Google Scholar
• Mehran L, Amouzegar A, Tohidi M, Moayedi M, and Azizi F: Serum free thyroxine concentration is associated with metabolic syndrome in euthyroid subjects. Thyroid, 2014.
   PubMed Web of Science ®Google Scholar
• Larsen CC, Dumitrescu A, Guerra-Arguero LM, Gallego-Suarez C, Vazquez-Mellado A, et al.: Incidental identification of a thyroid hormone receptor beta (THRB) gene variant in a family with autoimmune thyroid disease. Thyroid 23, 1638–1643, 2013.
   PubMed Web of Science ®Google Scholar
• Al-azzam SI, Alkhateeb AM, Al-Azzeh O, Alzoubi KH, and Khabour OF: The role of type II deiodinase polymorphisms in clinical management of hypothyroid patients treated with levothyroxine. Exp Clin Endocrinol Diabetes 121, 300–305, 2013.
   PubMed Web of Science ®Google Scholar
• Meacham LR, Chow EJ, Ness KK, Kamdar KY, Chen Y, et al.: Cardiovascular risk factors in adult survivors of pediatric cancer—a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev 19, 170–181, 2010.
   PubMed Web of Science ®Google Scholar
• de Haas EC, Oosting SF, Lefrandt JD, Wolffenbuttel BH, Sleijfer DT, et al.: The metabolic syndrome in cancer survivors. Lancet Oncol 11, 193–203, 2010.
   PubMed Web of Science ®Google Scholar